{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:18:00Z","timestamp":1793902680504,"version":"4.8.0"},"reference-count":524,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","heartrhythmjournal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.hrthm.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T19:28:35Z","timestamp":1557430115000},"page":"e301-e372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":760,"title":["2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy"],"prefix":"10.1016","volume":"16","author":[{"given":"Jeffrey A.","family":"Towbin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco C.C.","family":"Darrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Daubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"de Chillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene C.","family":"DePasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind Y.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"N.A. Mark","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Indik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Ingles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank I.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Mestroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia G.","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Saffitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhayan","family":"Sanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"van Tintelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2019.05.007_bib1","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/j.hrthm.2017.06.039","article-title":"HRS clinical document development methodology manual and policies: executive summary","volume":"14","author":"Indik","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib2","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIR.0000000000000312","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"133","author":"Halperin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib3","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.hrthm.2017.10.036","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2008.04.014","article-title":"ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities","volume":"5","author":"Epstein","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib6","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib7","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"Yancy","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib8","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib10","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America Practice Guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/hrt.63.5.287","article-title":"Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass","volume":"63","author":"McKenna","year":"1990","journal-title":"Br Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib14","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra0902923","article-title":"Inherited cardiomyopathies","volume":"364","author":"Watkins","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI200316336","article-title":"Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations","volume":"111","author":"Mogensen","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrthm.2019.05.007_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-8703(61)90513-0","article-title":"\u201cAuricularization\u201d of right ventricular pressure curve","volume":"61","author":"Dalla Volta","year":"1961","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.CIR.65.2.384","article-title":"Right ventricular dysplasia: a report of 24 adult cases","volume":"65","author":"Marcus","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/hrt.51.1.15","article-title":"Ventricular tachycardia of left bundle branch block configuration in patients with isolated right ventricular dilatation. Clinical and electrophysiological features","volume":"51","author":"Rowland","year":"1984","journal-title":"Br Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/hrt.71.3.215","volume":"71","author":"McKenna","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib20","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/01.CIR.97.20.2049","article-title":"Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21","volume":"97","author":"Coonar","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/europace\/euv061","article-title":"Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy","volume":"18","author":"Protonotarios","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib22","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-5","article-title":"Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)","volume":"355","author":"McKoy","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib23","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/hmg\/9.18.2761","article-title":"Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma","volume":"9","author":"Norgett","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib24","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ng1461","article-title":"Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Gerull","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/eurheartj\/ehl380","article-title":"Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease","volume":"28","author":"Syrris","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/509122","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2","volume":"79","author":"Syrris","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/eurheartj\/ehl530","article-title":"Arrhythmogenic right ventricular cardiomyopathy: a \u2018final common pathway' that defines clinical phenotype","volume":"28","author":"Vatta","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib28","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2010.11.061","article-title":"Arrhythmias and dilated cardiomyopathy common pathogenetic pathways?","volume":"57","author":"Towbin","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.hrthm.2011.03.040","article-title":"Desmosomal gene variants in patients with \u201cpossible ARVC.\u201d","volume":"8","author":"Towbin","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib30","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.jacc.2006.07.045","article-title":"Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype","volume":"48","author":"Sen-Chowdhry","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib31","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.104.532234","article-title":"Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy","volume":"112","author":"Norman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib32","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib33","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib34","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s000590050003","article-title":"The \"final common pathway\" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy","volume":"25","author":"Bowles","year":"2000","journal-title":"Herz"},{"key":"10.1016\/j.hrthm.2019.05.007_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0955-0674(98)80096-3","article-title":"The role of cytoskeletal proteins in cardiomyopathies","volume":"10","author":"Towbin","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/6474","article-title":"Etiologies of cardiomyopathy and heart failure","volume":"5","author":"Towbin","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib38","doi-asserted-by":"crossref","first-page":"H1313","DOI":"10.1152\/ajpheart.00816.2005","article-title":"Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures","volume":"290","author":"Hoshijima","year":"2006","journal-title":"Am J Physiology Heart Circ Physiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib39","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/heart.87.1.41","article-title":"Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia","volume":"87","author":"Niroomand","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2019.05.007_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1542-474X.2008.00241.x","article-title":"Arrhythmogenic right ventricular cardiomyopathy: a paradigm of overlapping disorders","volume":"13","author":"Towbin","year":"2008","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cardfail.2011.02.008","article-title":"Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis","volume":"17","author":"Wilmot","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib43","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1016\/j.hrthm.2014.07.024","article-title":"EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias","volume":"11","author":"Pedersen","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib44","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00246-018-1875-y","article-title":"Diagnosing ARVC in pediatric patients applying the revised task force criteria: importance of imaging, 12-Lead ECG, and genetics","volume":"39","author":"Steinmetz","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00246-015-1327-x","article-title":"Arrhythmogenic right ventricular cardiomyopathy\/dysplasia (ARVC\/D): review of 16 pediatric cases and a proposal of modified pediatric criteria","volume":"37","author":"Deshpande","year":"2016","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib46","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","article-title":"An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis","volume":"39","author":"Chatterjee","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib47","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1093\/eurheartj\/ehy410","article-title":"A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy: is this too good to be true?","volume":"39","author":"Calkins","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCEP.109.927202","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy diagnostic task force criteria: impact of new task force criteria","volume":"3","author":"Cox","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib49","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/oxfordjournals.eurheartj.a014756","article-title":"Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease","volume":"17","author":"Jaoude","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib50","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0735-1097(00)00997-9","article-title":"Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Nava","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib51","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.hrthm.2013.06.022","article-title":"Malignant arrhythmogenic right ventricular dysplasia\/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity","volume":"10","author":"Te Riele","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamacardio.2016.5034","article-title":"Evaluation of structural progression in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"2","author":"Mast","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjcard.2005.02.057","article-title":"Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"96","author":"Piccini","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib54","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/hrt.2009.182949","article-title":"Dynamic electrocardiographic changes in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"96","author":"Quarta","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2019.05.007_bib55","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1540-8167.2008.01140.x","article-title":"Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: toward improvement of diagnostic ECG criteria","volume":"19","author":"Cox","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelectrocard.2008.12.011","article-title":"The electrocardiogram in right ventricular cardiomyopathy\/dysplasia. How can the electrocardiogram assist in understanding the pathologic and functional changes of the heart in this disease?","volume":"42","author":"Marcus","year":"2009","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib57","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1542-474X.2003.08312.x","article-title":"Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited","volume":"8","author":"Peters","year":"2003","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib58","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjcard.2016.06.006","article-title":"Electrocardiographic abnormalities in disease-free black South Africans and correlations with echocardiographic indexes and early repolarization","volume":"118","author":"Lohrmann","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2016.10.044","article-title":"Anterior T-wave inversion in young white athletes and nonathletes: prevalence and significance","volume":"69","author":"Malhotra","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib60","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.amjcard.2004.12.060","article-title":"Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"95","author":"Marcus","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/CIRCULATIONAHA.108.838821","article-title":"Electrocardiographic features of arrhythmogenic right ventricular dysplasia","volume":"120","author":"Jain","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.hrthm.2015.08.031","article-title":"High interobserver variability in the assessment of epsilon waves: implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"13","author":"Platonov","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/jce.12925","article-title":"Electroanatomic correlates of depolarization abnormalities in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"27","author":"Tanawuttiwat","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib64","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/jce.12775","article-title":"Epsilon waves aid in the prognosis and risk stratification of patients with ARVC\/D","volume":"26","author":"Marcus","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib65","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/jce.12755","article-title":"Clinical significance of epsilon waves in arrhythmogenic cardiomyopathy","volume":"26","author":"Protonotarios","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib66","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCEP.108.832519","article-title":"New ECG criteria in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"2","author":"Cox","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib67","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000142293.60725.18","article-title":"Electrocardiographic features of arrhythmogenic right ventricular dysplasia\/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria","volume":"110","author":"Nasir","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib68","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/CIRCULATIONAHA.110.988287","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia\/cardiomyopathy genotype-phenotype follow-up study","volume":"123","author":"Cox","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib69","doi-asserted-by":"crossref","first-page":"f3","DOI":"10.1093\/europace\/eux202","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy: an electrocardiogram-based review","volume":"20","author":"Nunes de Alencar Neto","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib70","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib71","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1590\/S0066-782X2011000600002","article-title":"I Latin American guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary","volume":"96","author":"Andrade","year":"2011","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib72","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.hrthm.2016.03.039","article-title":"The ventricular ectopic QRS interval (VEQSI): diagnosis of arrhythmogenic right ventricular cardiomyopathy in patients with incomplete disease expression","volume":"13","author":"Bastiaenen","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jce.12544","article-title":"Premature ventricular contraction variability in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"26","author":"Camm","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib74","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.hrthm.2010.10.007","article-title":"Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"8","author":"Kamath","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib75","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.hrthm.2011.06.026","article-title":"Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations","volume":"8","author":"Bauce","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib76","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0002-9149(86)90690-9","article-title":"Usefulness of noninvasive studies for diagnosis of right ventricular dysplasia","volume":"57","author":"Manyari","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib77","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10554-015-0813-9","article-title":"Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy","volume":"32","author":"Reant","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2019.05.007_bib78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ehjci\/jew229","article-title":"Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging","volume":"18","author":"Haugaa","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2019.05.007_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hrthm.2004.01.001","article-title":"Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease)","volume":"1","author":"Kaplan","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib80","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/CIRCULATIONAHA.106.660241","article-title":"Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy provides novel insights into patterns of disease expression","volume":"115","author":"Sen-Chowdhry","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib81","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.hlc.2018.07.017","article-title":"Arrhythmogenic right ventricular cardiomyopathy: a review of living and deceased probands","volume":"28","author":"Blusztein","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hrthm.2019.05.007_bib82","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCULATIONAHA.109.913871","article-title":"Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia","volume":"122","author":"Corrado","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib83","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib84","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCEP.113.001224","article-title":"Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy","volume":"7","author":"Denis","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-8703(96)90416-0","article-title":"Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy","volume":"132","author":"Angelini","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib86","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/eurheartj\/ehn415","article-title":"Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an in\u00a0vitro validation of diagnostic criteria","volume":"29","author":"Basso","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib87","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1540-8167.2008.01228.x","article-title":"Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"19","author":"Avella","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib88","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jcin.2011.06.015","article-title":"Safety of endomyocardial biopsy in patients with arrhythmogenic right ventricular cardiomyopathy: a study analyzing 161 diagnostic procedures","volume":"4","author":"Paul","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2019.05.007_bib89","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/pace.12492","article-title":"Plakoglobin immunolocalization as a diagnostic test for arrhythmogenic right ventricular cardiomyopathy","volume":"37","author":"Ermakov","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib90","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.amjcard.2011.08.044","article-title":"Usefulness of immunostaining for plakoglobin as a diagnostic marker of arrhythmogenic right ventricular cardiomyopathy","volume":"109","author":"Munkholm","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib91","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0808138","article-title":"A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy","volume":"360","author":"Asimaki","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib92","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2009.11.020","article-title":"Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy","volume":"55","author":"Xu","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib93","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/humu.22332","article-title":"Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics","volume":"34","author":"Sikkema-Raddatz","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hrthm.2019.05.007_bib94","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2010.12.036","article-title":"Distinguishing arrhythmogenic right ventricular cardiomyopathy\/dysplasia-associated mutations from background genetic noise","volume":"57","author":"Kapplinger","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib95","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib96","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hrthm.2019.05.007_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2015.17701","article-title":"Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records","volume":"315","author":"Van Driest","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.05.007_bib98","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1101\/gr.183483.114","article-title":"Actionable exomic incidental findings in 6503 participants: challenges of variant classification","volume":"25","author":"Amendola","year":"2015","journal-title":"Genome Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib99","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajhg.2016.06.001","article-title":"Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research Consortium","volume":"99","author":"Amendola","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib101","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMsa1507092","article-title":"Genetic misdiagnoses and the potential for health disparities","volume":"375","author":"Manrai","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib102","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ejhg.2010.19","article-title":"The p.A897KfsX4 frameshift variation in desmocollin-2 is not a causative mutation in arrhythmogenic right ventricular cardiomyopathy","volume":"18","author":"De Bortoli","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib103","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/ncpcardio1434","article-title":"Variations in DSG2: V56M, V158G and V920G are not pathogenic for arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Posch","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000263456","article-title":"Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients\u2014disease-causing or innocent bystanders?","volume":"115","author":"Christensen","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.hrthm.2019.05.007_bib105","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/hrt.2010.205880","article-title":"Plakophilin 2A is the dominant isoform in human heart tissue: consequences for the genetic screening of arrhythmogenic right ventricular cardiomyopathy","volume":"97","author":"Gandjbakhch","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2019.05.007_bib106","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ejhg.2012.283","article-title":"New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants","volume":"21","author":"Andreasen","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib107","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/eurheartj\/ehv122","volume":"36","author":"Mogensen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib108","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen\u2014the Clinical Genome Resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib109","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gim.2017.218","article-title":"Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel","volume":"20","author":"Kelly","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/s41436-018-0267-2","article-title":"Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): lessons learned and plans for the future","volume":"21","author":"Milko","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib111","doi-asserted-by":"crossref","first-page":"e002460","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the clinical validity of hypertrophic cardiomyopathy genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib112","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1329","article-title":"ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating","volume":"36","author":"Bienengraeber","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib113","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/344208","article-title":"Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy","volume":"71","author":"Rampazzo","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib114","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.110.005405","article-title":"Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes","volume":"124","author":"Taylor","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/eurheartj\/ehs373","article-title":"Mutations in the area composita protein alphaT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy","volume":"34","author":"van Hengel","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib116","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/jce.13621","article-title":"Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)","volume":"29","author":"Murray","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib117","first-page":"1063","article-title":"Arrhythmogenic right ventricular cardiomyopathy: implications of next-generation sequencing in appropriate diagnosis","volume":"19","author":"Medeiros-Domingo","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib118","doi-asserted-by":"crossref","first-page":"e001605","DOI":"10.1161\/CIRCGENETICS.116.001605","article-title":"Identification of cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy","volume":"10","author":"Mayosi","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib119","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/chd.12462","article-title":"Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy","volume":"12","author":"Turkowski","year":"2017","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hrthm.2019.05.007_bib120","doi-asserted-by":"crossref","first-page":"e002123","DOI":"10.1161\/CIRCGEN.118.002123","article-title":"Whole-exome sequencing identifies pathogenic variants in TJP1 gene associated with arrhythmogenic cardiomyopathy","volume":"11","author":"De Bortoli","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib121","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2011.01.016","article-title":"Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy","volume":"88","author":"Norton","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib122","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ejhg.2012.39","article-title":"Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7 is caused by a DES mutation","volume":"20","author":"Hedberg","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib123","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1086\/504393","article-title":"DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"79","author":"Awad","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib124","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.RES.0000241482.19382.c6","article-title":"Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"99","author":"Yang","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib125","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1086\/521633","article-title":"A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy","volume":"81","author":"Asimaki","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib126","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.jacc.2003.10.021","article-title":"Mutations in Cypher\/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction","volume":"42","author":"Vatta","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib127","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehr451","article-title":"Mutations in the Lamin A\/C gene mimic arrhythmogenic right ventricular cardiomyopathy","volume":"33","author":"Quarta","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0092-8674(04)00405-2","article-title":"Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block","volume":"117","author":"Pashmforoush","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2019.05.007_bib129","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.hrthm.2019.05.007_bib130","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2009.05.038","article-title":"Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy","volume":"54","author":"Brauch","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib131","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.0000144458.58660.BB","article-title":"SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia","volume":"110","author":"McNair","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib132","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene","volume":"82","author":"Merner","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib133","doi-asserted-by":"crossref","first-page":"e005324","DOI":"10.1161\/CIRCEP.117.005324","article-title":"Large genomic rearrangements of desmosomal genes in italian arrhythmogenic cardiomyopathy patients","volume":"10","author":"Pilichou","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib134","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1399-0004.2012.01950.x","article-title":"Detection of genomic deletions of PKP2 in arrhythmogenic right ventricular cardiomyopathy","volume":"83","author":"Roberts","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib135","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12265-008-9025-1","article-title":"Genetic evaluation of familial cardiomyopathy","volume":"1","author":"Judge","year":"2008","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib136","doi-asserted-by":"crossref","first-page":"e001884","DOI":"10.1161\/CIRCGENETICS.117.001844","article-title":"Technical advances for the clinical genomic evaluation of sudden cardiac death: verification of next-generation sequencing panels for hereditary cardiovascular conditions using formalin-fixed paraffin-embedded tissues and dried blood spots","volume":"10","author":"Baudhuin","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib137","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1309\/VLA7TT9EQ05FFVN4","article-title":"Postmortem genetic testing for conventional autopsy-negative sudden unexplained death: an evaluation of different DNA extraction protocols and the feasibility of mutational analysis from archival paraffin-embedded heart tissue","volume":"129","author":"Carturan","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib138","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib139","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.2009.1787","article-title":"Use of genetics in the clinical evaluation of cardiomyopathy","volume":"302","author":"Judge","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.05.007_bib140","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/europace\/euu128","article-title":"Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype","volume":"16","author":"Lopez-Ayala","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib141","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib142","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib143","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/europace\/euq104","article-title":"Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: spectrum of mutations and clinical impact in practice","volume":"12","author":"Fressart","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib144","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCGENETICS.113.000122","article-title":"Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Bao","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib146","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/eurheartj\/ehv387","article-title":"Approach to family screening in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"37","author":"Te Riele","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib147","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1161\/CIRCULATIONAHA.110.976936","article-title":"Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria","volume":"123","author":"Quarta","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib148","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2013.04.084","article-title":"Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy","volume":"62","author":"Perrin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib149","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/eurjhf\/hfs191","article-title":"Gender-specific differences in major cardiac events and mortality in lamin A\/C mutation carriers","volume":"15","author":"van Rijsingen","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib151","doi-asserted-by":"crossref","first-page":"e0121723","DOI":"10.1371\/journal.pone.0121723","article-title":"Clinical and functional characterization of a novel mutation in lamin a\/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy","volume":"10","author":"Forleo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2019.05.007_bib152","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jjcc.2015.10.013","article-title":"LMNA cardiomyopathy detected in Japanese arrhythmogenic right ventricular cardiomyopathy cohort","volume":"68","author":"Kato","year":"2016","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib153","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/jce.12984","article-title":"LMNA-mediated arrhythmogenic right ventricular cardiomyopathy and Charcot-Marie-Tooth type 2B1: a patient-discovered unifying diagnosis","volume":"27","author":"Liang","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib154","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1016\/j.ijcard.2013.04.177","article-title":"A case of lamin A\/C mutation cardiomyopathy with overlap features of ARVC: a critical role of genetic testing","volume":"168","author":"Valtuille","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib155","doi-asserted-by":"crossref","first-page":"e001603","DOI":"10.1161\/CIRCGENETICS.116.001603","article-title":"Gene-based risk stratification for cardiac disorders in LMNA mutation carriers","volume":"10","author":"Nishiuchi","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib156","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib157","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","article-title":"Primary prevention of sudden death in patients with lamin A\/C gene mutations","volume":"354","author":"Meune","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib158","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/cge.12458","article-title":"A mutation in the Z-line Cypher\/ZASP protein is associated with arrhythmogenic right ventricular cardiomyopathy","volume":"88","author":"Lopez-Ayala","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib159","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/eurheartj\/ehu077","article-title":"The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus","volume":"36","author":"Milting","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0004.2012.01919.x","article-title":"The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43","volume":"83","author":"Hodgkinson","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib161","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib162","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib163","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/gim.2017.40","article-title":"Electronic health record phenotype in subjects with genetic variants associated with arrhythmogenic right ventricular cardiomyopathy: a study of 30,716 subjects with exome sequencing","volume":"19","author":"Haggerty","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib164","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIR.0b013e31825b07f8","article-title":"Genetics and cardiovascular disease: a policy statement from the American Heart Association","volume":"126","author":"Ashley","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1751-7133.2008.08201.x","article-title":"Family history: an essential tool for cardiovascular genetic medicine","volume":"14","author":"Morales","year":"2008","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib166","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.hrthm.2011.07.017","article-title":"The emerging role of the cardiac genetic counselor","volume":"8","author":"Ingles","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib167","doi-asserted-by":"crossref","first-page":"e000329","DOI":"10.1136\/openhrt-2015-000329","article-title":"Inpatient detection of cardiac-inherited disease: the impact of improving family history taking","volume":"3","author":"Waddell-Smith","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.hrthm.2019.05.007_bib168","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/CIRCGENETICS.110.959387","article-title":"A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management","volume":"6","author":"Dunn","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib169","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.hrthm.2009.07.041","article-title":"Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene","volume":"6","author":"van Tintelen","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib170","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib171","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacep.2015.08.004","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy in the pediatric population: clinical characterization and comparison with adult-onset disease","volume":"1","author":"Te Riele","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib172","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jacc.2006.06.045","article-title":"Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"48","author":"Dalal","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib173","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0735-1097(02)02307-0","article-title":"Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy\/dysplasia reveals a need to broaden diagnostic criteria","volume":"40","author":"Hamid","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib174","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jacc.2014.04.044","article-title":"Yield of serial evaluation in at-risk family members of patients with ARVD\/C","volume":"64","author":"te Riele","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib175","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.jacc.2016.08.061","article-title":"Right ventricular imaging and computer simulation for electromechanical substrate characterization in arrhythmogenic right ventricular cardiomyopathy","volume":"68","author":"Mast","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib176","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.mayocp.2016.08.008","article-title":"The promise and peril of precision medicine: phenotyping still matters most","volume":"91","author":"Ackerman","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib177","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib178","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/01.CIR.0000143375.93288.82","article-title":"Natural history and risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"110","author":"Hulot","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib179","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment","volume":"64","author":"Link","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib180","doi-asserted-by":"crossref","first-page":"e006242","DOI":"10.1161\/JAHA.117.006242","article-title":"Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: predictors of appropriate therapy, outcomes, and complications","volume":"6","author":"Orgeron","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib181","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jacc.2004.08.068","article-title":"The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)","volume":"45","author":"Hodgkinson","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib182","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib183","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.jacc.2016.09.951","article-title":"Arrhythmogenic right ventricular cardiomyopathy: clinical course and predictors of arrhythmic risk","volume":"68","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib184","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/eurheartj\/ehr040","article-title":"Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry","volume":"32","author":"Pinamonti","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib185","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib186","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.05.007_bib187","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib188","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2014AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib189","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter-defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib190","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jacep.2016.02.019","article-title":"Potentially lethal ventricular arrhythmias and heart failure in arrhythmogenic right ventricular cardiomyopathy: what are the differences between men and women?","volume":"2","author":"Kimura","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib191","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib192","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/eurheartj\/ehs257","article-title":"Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice","volume":"33","author":"Zannad","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib193","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib194","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib195","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/ejhf.1160","article-title":"Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction","volume":"20","author":"Abdul-Rahim","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib196","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIR.0b013e3182618569","volume":"126","author":"Tracy","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib197","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jacc.2010.09.046","article-title":"Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice","volume":"57","author":"Fabritz","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib198","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/europace\/eul053","article-title":"Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"8","author":"Wlodarska","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib199","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib200","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/eurjhf\/hfs073","article-title":"Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis","volume":"14","author":"Lip","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib201","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib202","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib203","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2013.03.087","article-title":"Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy)","volume":"62","author":"Ruwald","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib204","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib205","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2013.4598","article-title":"Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial","volume":"309","author":"Gasparini","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.05.007_bib206","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jce.12273","article-title":"Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study","volume":"25","author":"Saeed","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib207","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry","volume":"54","author":"Marcus","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib208","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.05.007_bib209","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.hrthm.2016.12.010","article-title":"Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"14","author":"Ermakov","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib210","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib211","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/bph.13807","article-title":"Multiple targets for flecainide action: implications for cardiac arrhythmogenesis","volume":"175","author":"Salvage","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib212","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","article-title":"Catheter ablation of ventricular tachycardia in nonischemic heart disease","volume":"5","author":"Tokuda","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib213","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib214","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.hrthm.2015.05.036","article-title":"Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group study","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.hrthm.2017.03.008","article-title":"Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: an analysis from the International VT Ablation Center Collaborative Group","volume":"14","author":"Tzou","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib216","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCEP.115.003562","article-title":"Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Santangeli","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib217","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.hrthm.2010.12.015","article-title":"Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease","volume":"8","author":"Mallidi","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib218","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hrthm.2014.12.018","article-title":"Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"12","author":"Philips","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib219","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","article-title":"Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation","volume":"4","author":"Bai","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib220","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/europace\/eux056","volume":"19","author":"Berruezo","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib221","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2007.03.049","article-title":"Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"50","author":"Dalal","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib222","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib223","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib224","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacc.2015.11.041","article-title":"Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial","volume":"67","author":"Marchlinski","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib225","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1161\/CIRCULATIONAHA.108.788604","article-title":"Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter THERMOCOOL ventricular tachycardia ablation trial","volume":"118","author":"Stevenson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib226","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1540-8159.2008.00999.x","article-title":"Ablation of ventricular tachycardia in patients with structural heart disease","volume":"31","author":"Zeppenfeld","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib227","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/CIRCULATIONAHA.106.655720","article-title":"Catheter ablation for ventricular tachycardia","volume":"115","author":"Stevenson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib228","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2004.01.029","article-title":"Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars","volume":"43","author":"Soejima","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib229","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0735-1097(00)00615-X","article-title":"Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group","volume":"35","author":"Calkins","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib230","doi-asserted-by":"crossref","first-page":"e004357","DOI":"10.1161\/CIRCEP.116.004357","article-title":"Multicenter experience with catheter ablation for ventricular tachycardia in lamin A\/C cardiomyopathy","volume":"9","author":"Kumar","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib231","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0972-6292(16)30671-4","article-title":"Successful right ventricular tachycardia ablation in a patient with left ventricular non-compaction cardiomyopathy","volume":"13","author":"Honarbakhsh","year":"2013","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib232","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ipej.2015.09.002","article-title":"Case report: ablation of diffuse inter-trabecular substrate in a patient with isolated ventricular non-compaction","volume":"15","author":"Jackson","year":"2015","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib233","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4070\/kcj.2016.0328","article-title":"Catheter ablation of ventricular tachycardia\/fibrillation in a patient with right ventricular amyloidosis with initial manifestations mimicking arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"47","author":"Chung","year":"2017","journal-title":"Korean Circ J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib234","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1540-8167.2005.00321.x","article-title":"Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart","volume":"17","author":"Mlcochova","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1540-8175.2005.03191.x","article-title":"Fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male","volume":"22","author":"Magage","year":"2005","journal-title":"Echocardiography"},{"key":"10.1016\/j.hrthm.2019.05.007_bib236","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/europace\/eux056","article-title":"Epicardial ablation may not be necessary in all patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy and frequent ventricular tachycardia: author's reply","volume":"19","author":"Berruezo","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib237","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","article-title":"Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"5","author":"Philips","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib238","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00001573-199501000-00004","article-title":"Arrhythmogenic right ventricular dysplasia","volume":"10","author":"Fontaine","year":"1995","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib239","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"318","author":"Thiene","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib240","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2003.03.002","article-title":"Does sports activity enhance the risk of sudden death in adolescents and young adults?","volume":"42","author":"Corrado","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib241","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.296.13.1593","article-title":"Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program","volume":"296","author":"Corrado","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.05.007_bib242","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85923","article-title":"Central role for GSK3beta in the pathogenesis of arrhythmogenic cardiomyopathy","volume":"1","author":"Chelko","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.hrthm.2019.05.007_bib243","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.106.624502","article-title":"Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice","volume":"114","author":"Kirchhof","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib244","doi-asserted-by":"crossref","first-page":"H174","DOI":"10.1152\/ajpheart.00295.2015","article-title":"Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt\/beta-catenin signaling","volume":"310","author":"Martherus","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib245","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41467-017-00127-0","article-title":"Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm","volume":"8","author":"Cerrone","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2019.05.007_bib246","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2015.01.045","article-title":"Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2","volume":"65","author":"Cruz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib247","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.cir.0000435708.67487.da","article-title":"Guide to the assessment of physical activity: clinical and research applications: a scientific statement from the American Heart Association","volume":"128","author":"Strath","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib248","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1161\/CIR.0000000000000237","volume":"132","author":"Levine","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib249","first-page":"e256","article-title":"Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology","volume":"132","author":"Maron","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib250","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1249\/mss.0b013e3180616b27","article-title":"Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association","volume":"39","author":"Haskell","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib251","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1249\/MSS.0b013e318213fefb","article-title":"American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise","volume":"43","author":"Garber","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib252","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1249\/MSS.0b013e31821ece12","article-title":"2011 Compendium of physical activities: a second update of codes and MET values","volume":"43","author":"Ainsworth","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib253","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib254","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hrthm.2015.08.035","article-title":"Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers","volume":"13","author":"Sawant","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib255","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.181","article-title":"Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members","volume":"16","author":"Saberniak","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib256","doi-asserted-by":"crossref","first-page":"e001471","DOI":"10.1161\/JAHA.114.001471","article-title":"Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy in patients without desmosomal mutations","volume":"3","author":"Sawant","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib257","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/hrt.2009.189621","article-title":"Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin","volume":"96","author":"La Gerche","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2019.05.007_bib258","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/eurheartj\/ehv110","article-title":"Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Ruwald","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib259","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jacep.2018.01.010","article-title":"Harmful Effects of exercise intensity and exercise duration in patients with arrhythmogenic cardiomyopathy","volume":"4","author":"Lie","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjcard.2017.03.251","article-title":"Comparison of features of fatal versus nonfatal cardiac arrest in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"120","author":"Gupta","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib261","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","article-title":"Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a multicenter study","volume":"30","author":"Corrado","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib262","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/jce.13668","article-title":"Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators","volume":"29","author":"Wang","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib263","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.febslet.2014.02.008","article-title":"Arrhythmogenic cardiomyopathy and Brugada syndrome: diseases of the connexome","volume":"588","author":"Agullo-Pascual","year":"2014","journal-title":"FEBS Lett"},{"key":"10.1016\/j.hrthm.2019.05.007_bib264","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrcardio.2017.103","article-title":"Unmasking the molecular link between arrhythmogenic cardiomyopathy and Brugada syndrome","volume":"14","author":"Moncayo-Arlandi","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCGENETICS.113.000097","article-title":"Homozygous founder mutation in desmocollin-2 (DSC2) causes arrhythmogenic cardiomyopathy in the Hutterite population","volume":"6","author":"Gerull","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib266","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cardiores.2004.10.005","article-title":"Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1","volume":"65","author":"Beffagna","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib267","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/humu.22765","article-title":"The ARVD\/C genetic variants database: 2014 update","volume":"36","author":"Lazzarini","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hrthm.2019.05.007_bib268","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.tcm.2009.12.001","article-title":"Cell-cell connection to cardiac disease","volume":"19","author":"Sheikh","year":"2009","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib269","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejcb.2005.11.003","article-title":"The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal proteins","volume":"85","author":"Franke","year":"2006","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib270","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1152\/physrev.00041.2011","article-title":"Dynamic of ion channel expression at the plasma membrane of cardiomyocytes","volume":"92","author":"Balse","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.hrthm.2019.05.007_bib271","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1083\/jcb.118.3.671","article-title":"Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin","volume":"118","author":"Knudsen","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib272","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejcb.2006.02.009","article-title":"The area composita of adhering junctions connecting heart muscle cells of vertebrates. II. Colocalizations of desmosomal and fascia adhaerens molecules in the intercalated disk","volume":"85","author":"Borrmann","year":"2006","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib273","doi-asserted-by":"crossref","first-page":"20201","DOI":"10.1074\/jbc.270.34.20201","article-title":"Identification of plakoglobin domains required for association with N-cadherin and alpha-catenin","volume":"270","author":"Sacco","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2019.05.007_bib274","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.RES.0000156274.72390.2c","article-title":"Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure","volume":"96","author":"Kostetskii","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib275","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.RES.0000181132.11393.18","article-title":"Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis","volume":"97","author":"Li","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib276","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.yjmcc.2007.11.013","article-title":"N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility","volume":"44","author":"Li","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib277","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCRESAHA.114.302810","article-title":"The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib278","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.joa.2015.11.003","article-title":"Mechanisms of cardiac arrhythmias","volume":"32","author":"Tse","year":"2016","journal-title":"J Arrhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib279","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1196\/annals.1380.016","article-title":"The integration of spontaneous intracellular Ca2+ cycling and surface membrane ion channel activation entrains normal automaticity in cells of the heart's pacemaker","volume":"1080","author":"Lakatta","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.hrthm.2019.05.007_bib280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pharmthera.2005.01.005","article-title":"Physiology and pharmacology of the cardiac pacemaker (\"funny\") current","volume":"107","author":"Baruscotti","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.hrthm.2019.05.007_bib281","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1341.013","article-title":"Rhythmic Ca2+ oscillations drive sinoatrial nodal cell pacemaker function to make the heart tick","volume":"1047","author":"Vinogradova","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.hrthm.2019.05.007_bib282","doi-asserted-by":"crossref","first-page":"e81633","DOI":"10.1371\/journal.pone.0081633","article-title":"Complete atrial-specific knockout of sodium-calcium exchange eliminates sinoatrial node pacemaker activity","volume":"8","author":"Groenke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2019.05.007_bib283","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/nar\/30.1.52","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"30","author":"Hamosh","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib284","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yjmcc.2013.06.003","article-title":"Cardiac sodium transport and excitation-contraction coupling","volume":"61","author":"Aronsen","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib285","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ccep.2014.08.007","article-title":"Diseases caused by mutations in Nav1.5 interacting proteins","volume":"6","author":"Kyle","year":"2014","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hrthm.2019.05.007_bib286","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/europace\/eun202","article-title":"The cardiac sodium channel mutation delQKP 1507-1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death","volume":"10","author":"Shi","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2019.05.007_bib287","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.tcm.2014.02.001","article-title":"Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome","volume":"24","author":"Cerrone","year":"2014","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib288","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib289","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.RES.0000050585.07097.D7","article-title":"A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill","volume":"92","author":"Groenewegen","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib290","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.05.007_bib291","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ymgme.2007.10.009","article-title":"SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia","volume":"93","author":"Shan","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.hrthm.2019.05.007_bib292","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.hrthm.2014.04.042","article-title":"Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy","volume":"11","author":"Beckermann","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib293","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.109.201418","article-title":"Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes","volume":"105","author":"Sato","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib294","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.113.003077","article-title":"Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype","volume":"129","author":"Cerrone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib295","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis","volume":"113","author":"Te Riele","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib296","doi-asserted-by":"crossref","first-page":"10342","DOI":"10.1038\/ncomms10342","article-title":"Nanoscale visualization of functional adhesion\/excitability nodes at the intercalated disc","volume":"7","author":"Leo-Macias","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.hrthm.2019.05.007_bib297","doi-asserted-by":"crossref","first-page":"e002149","DOI":"10.1161\/JAHA.115.002149","article-title":"Arrhythmogenic phenotype in dilated cardiomyopathy: natural history and predictors of life-threatening arrhythmias","volume":"4","author":"Spezzacatene","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib298","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1253\/circj.CJ-15-0854","article-title":"Roles of nebulin family members in the heart","volume":"79","author":"Bang","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib299","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1074\/jbc.R110.174268","article-title":"Cardiac Z-disc signaling network","volume":"286","author":"Frank","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2019.05.007_bib300","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00109-005-0033-1","article-title":"The sarcomeric Z-disc: a nodal point in signalling and disease","volume":"84","author":"Frank","year":"2006","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.hrthm.2019.05.007_bib301","doi-asserted-by":"crossref","first-page":"569628","DOI":"10.1155\/2011\/569628","article-title":"The sarcomeric Z-disc and Z-discopathies","volume":"2011","author":"Knoll","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib302","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1016\/S0021-9258(19)50420-3","article-title":"Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11","volume":"267","author":"Beggs","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2019.05.007_bib303","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cell.2014.10.056","article-title":"The structure and regulation of human muscle alpha-actinin","volume":"159","author":"Ribeiro Ede","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2019.05.007_bib304","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12013-012-9430-6","article-title":"Z-disc transcriptional coupling, sarcomeroptosis and mechanoptosis [corrected]","volume":"66","author":"Knoll","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.hrthm.2019.05.007_bib305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10974-009-9189-6","article-title":"The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling","volume":"30","author":"Luther","year":"2009","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.hrthm.2019.05.007_bib306","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1007\/s00018-008-8080-8","article-title":"Alpha-actinin structure and regulation","volume":"65","author":"Sjoblom","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.hrthm.2019.05.007_bib307","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13578-015-0029-7","article-title":"The actinin family of actin cross-linking proteins\u2014a genetic perspective","volume":"5","author":"Murphy","year":"2015","journal-title":"Cell Biosci"},{"key":"10.1016\/j.hrthm.2019.05.007_bib308","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.148.1.115","article-title":"Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein","volume":"148","author":"Thompson","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib309","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1242\/jcs.02484","article-title":"The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins","volume":"118","author":"Gontier","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.hrthm.2019.05.007_bib310","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1083\/jcb.151.2.235","article-title":"Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin","volume":"151","author":"van der Ven","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib311","doi-asserted-by":"crossref","first-page":"41234","DOI":"10.1074\/jbc.M007493200","article-title":"FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle","volume":"275","author":"Faulkner","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2019.05.007_bib312","first-page":"1595","article-title":"Myozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines","volume":"98","author":"Takada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2019.05.007_bib313","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/brain\/awm271","article-title":"Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients","volume":"130","author":"Kley","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.hrthm.2019.05.007_bib314","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/431959","article-title":"A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy","volume":"77","author":"Vorgerd","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib315","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1083\/jcb.146.2.465","article-title":"ZASP: a new Z-band alternatively spliced PDZ-motif protein","volume":"146","author":"Faulkner","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib316","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.yexcr.2005.12.036","article-title":"Zasp\/Cypher internal ZM-motif containing fragments are sufficient to co-localize with alpha-actinin\u2014analysis of patient mutations","volume":"312","author":"Klaavuniemi","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib317","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1083\/jcb.200107092","article-title":"Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy","volume":"155","author":"Zhou","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib318","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/hmg\/ddn400","article-title":"Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death","volume":"18","author":"Zheng","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib319","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/bi901086v","article-title":"Cell membrane expression of cardiac sodium channel Na(v)1.5 is modulated by alpha-actinin-2 interaction","volume":"49","author":"Ziane","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.hrthm.2019.05.007_bib320","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1074\/jbc.M311849200","article-title":"A Cypher\/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C","volume":"279","author":"Arimura","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2019.05.007_bib321","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/CIRCEP.111.969220","article-title":"Loss of function of hNav1.5 by a ZASP1 mutation associated with intraventricular conduction disturbances in left ventricular noncompaction","volume":"5","author":"Xi","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib322","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/S0006-3495(00)76506-4","article-title":"Distribution of proteins implicated in excitation-contraction coupling in rat ventricular myocytes","volume":"79","author":"Scriven","year":"2000","journal-title":"Biophys J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib323","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbrc.2006.07.189","article-title":"Density and sub-cellular distribution of cardiac and neuronal sodium channel isoforms in rat ventricular myocytes","volume":"348","author":"Brette","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hrthm.2019.05.007_bib324","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0969-2126(01)00619-0","article-title":"Crystal structure of the alpha-actinin rod reveals an extensive torsional twist","volume":"9","author":"Ylanne","year":"2001","journal-title":"Structure"},{"key":"10.1016\/j.hrthm.2019.05.007_bib325","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.bpj.2011.06.024","article-title":"Electron microscopy and x-ray diffraction evidence for two Z-band structural states","volume":"101","author":"Perz-Edwards","year":"2011","journal-title":"Biophys J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib326","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-5793(01)02505-4","article-title":"A discrete amino terminal domain of Kv1.5 and Kv1.4 potassium channels interacts with the spectrin repeats of alpha-actinin-2","volume":"498","author":"Cukovic","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.hrthm.2019.05.007_bib327","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0014-5793(00)01521-0","article-title":"alpha-actinin-2 couples to cardiac Kv1.5 channels, regulating current density and channel localization in HEK cells","volume":"473","author":"Maruoka","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.hrthm.2019.05.007_bib328","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.RES.0000253095.44186.72","article-title":"Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2","volume":"100","author":"Lu","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib329","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12881-014-0099-0","article-title":"Exome sequencing identifies a mutation in the ACTN2 gene in a family with idiopathic ventricular fibrillation, left ventricular noncompaction, and sudden death","volume":"15","author":"Bagnall","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib330","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCGENETICS.113.000486","article-title":"Novel alpha-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study","volume":"7","author":"Girolami","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib331","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s004410051196","article-title":"The internal and external protein scaffold of the T-tubular system in cardiomyocytes","volume":"294","author":"Kostin","year":"1998","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib332","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jmcc.1996.0021","article-title":"Altered interactions among thin filament proteins modulate cardiac function","volume":"28","author":"Solaro","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib333","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1054\/jcaf.2002.129263","article-title":"The extracellular connections: the role of integrins in myocardial remodeling","volume":"8","author":"Ross","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib334","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.RES.0000096363.85588.9A","article-title":"Loaded shortening, power output, and rate of force redevelopment are increased with knockout of cardiac myosin binding protein-C","volume":"93","author":"Korte","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1050-1738(02)00184-6","article-title":"Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function","volume":"12","author":"Capetanaki","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib336","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCGENETICS.113.000103","article-title":"The novel desmin mutant p.A120D impairs filament formation, prevents intercalated disk localization, and causes sudden cardiac death","volume":"6","author":"Brodehl","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib337","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/CIRCULATIONAHA.117.028719","article-title":"Novel desmin mutation p.Glu401Asp impairs filament formation, disrupts cell membrane integrity, and causes severe arrhythmogenic left ventricular cardiomyopathy\/dysplasia","volume":"137","author":"Berm\u00fadez-Jim\u00e9nez","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib338","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/NEN.0b013e3181d71305","article-title":"Divergent molecular effects of desmin mutations on protein assembly in myofibrillar myopathy","volume":"69","author":"Levin","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib339","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib340","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1093\/hmg\/ddq387","article-title":"De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy","volume":"19","author":"Klauke","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib341","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1074\/jbc.M111.313841","article-title":"Dual color photoactivation localization microscopy of cardiomyopathy-associated desmin mutants","volume":"287","author":"Brodehl","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2019.05.007_bib342","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12471-011-0233-y","article-title":"Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D","volume":"20","author":"van Spaendonck-Zwarts","year":"2012","journal-title":"Neth Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib343","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM200003163421104","article-title":"Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene","volume":"342","author":"Dalakas","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib344","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.hrthm.2010.04.023","article-title":"Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks","volume":"7","author":"Otten","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib345","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","article-title":"Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history","volume":"108","author":"Seidman","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib346","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib347","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib348","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.hrthm.2019.05.007_bib349","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001735","article-title":"Genetic testing in pediatric left ventricular noncompaction","volume":"10","author":"Miller","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCGENETICS.110.959270","article-title":"Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype","volume":"4","author":"Probst","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib351","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/hrt.2007.134684","article-title":"Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes","volume":"94","author":"Kaski","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2019.05.007_bib352","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/gim.2017.79","article-title":"Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup","volume":"20","author":"Ko","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib353","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jacc.2017.12.019","article-title":"Genetics, clinical features, and long-term outcome of noncompaction cardiomyopathy","volume":"71","author":"van Waning","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib354","doi-asserted-by":"crossref","first-page":"e006210","DOI":"10.1161\/JAHA.117.006210","article-title":"A wide and specific spectrum of genetic variants and genotype-phenotype correlations revealed by next-generation sequencing in patients with left ventricular noncompaction","volume":"6","author":"Wang","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib355","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.CIR.100.22.2248","article-title":"Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children","volume":"100","author":"Bonnet","year":"1999","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.hrthm.2019.05.007_bib356","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0022-2828(91)90019-I","article-title":"Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart","volume":"23","author":"DaTorre","year":"1991","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib357","first-page":"401","article-title":"[Cellular electrophysiological basis of proarrhythmic and antiarrhythmic effects of ischemia-related lipid metabolites]","volume":"41","author":"Arita","year":"1993","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.hrthm.2019.05.007_bib358","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1073\/pnas.89.14.6452","article-title":"Long-chain fatty acids activate calcium channels in ventricular myocytes","volume":"89","author":"Huang","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2019.05.007_bib359","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1006\/jmcc.1997.0409","article-title":"Modulation of cardiac gap junctions: the mode of action of arachidonic acid","volume":"29","author":"Schmilinsky-Fluri","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib360","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/humu.23315","article-title":"Functional and molecular studies in primary carnitine deficiency","volume":"38","author":"Frigeni","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hrthm.2019.05.007_bib361","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.hrthm.2019.05.007_bib362","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","article-title":"Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings","volume":"24","author":"Holmgren","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib363","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.2006-1866","article-title":"Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases","volume":"119","author":"Debray","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.hrthm.2019.05.007_bib364","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ceca.2016.03.003","article-title":"Mitochondrial cytopathies","volume":"60","author":"El-Hattab","year":"2016","journal-title":"Cell Calcium"},{"key":"10.1016\/j.hrthm.2019.05.007_bib365","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF01799112","article-title":"Clinical presentation of mitochondrial disorders in childhood","volume":"19","author":"Munnich","year":"1996","journal-title":"J Inherit Metab Dis"},{"issue":"Pt 2","key":"10.1016\/j.hrthm.2019.05.007_bib366","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/brain\/118.2.339","article-title":"Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients","volume":"118","author":"Jackson","year":"1995","journal-title":"Brain"},{"issue":"Suppl 1","key":"10.1016\/j.hrthm.2019.05.007_bib367","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1177\/0883073899014001051","article-title":"Does the patient have a mitochondrial encephalomyopathy?","volume":"14","author":"DiMauro","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib368","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pediatrneurol.2007.12.001","article-title":"Presentation and diagnosis of mitochondrial disorders in children","volume":"38","author":"Koenig","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"Pt 5","key":"10.1016\/j.hrthm.2019.05.007_bib369","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/brain\/109.5.915","article-title":"The clinical features of mitochondrial myopathy","volume":"109","author":"Petty","year":"1986","journal-title":"Brain"},{"key":"10.1016\/j.hrthm.2019.05.007_bib370","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1338.004","article-title":"Hearing loss in mitochondrial disorders","volume":"1042","author":"Hsu","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.hrthm.2019.05.007_bib371","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0b013e3181d0ccf4","article-title":"Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA","volume":"74","author":"Wahbi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2019.05.007_bib372","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","article-title":"Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects","volume":"91","author":"Anan","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib373","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0002-9149(02)02723-6","article-title":"Left ventricular hypertrabeculation\/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders","volume":"90","author":"Stollberger","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib374","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/heartjnl-2012-302816","article-title":"Isolated left ventricular non-compaction controversies in diagnostic criteria, adverse outcomes and management","volume":"99","author":"Thavendiranathan","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2019.05.007_bib375","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehm481","article-title":"Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?","volume":"29","author":"Kohli","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib376","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0002-9440(10)65738-0","article-title":"Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy","volume":"153","author":"Arbustini","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib377","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI24405","article-title":"Mitochondrial energy metabolism in heart failure: a question of balance","volume":"115","author":"Huss","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrthm.2019.05.007_bib378","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0140-6736(91)90057-V","article-title":"Assessment of the mitochondrial respiratory chain","volume":"338","author":"Rustin","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib379","first-page":"CD004426","article-title":"Treatment for mitochondrial disorders","author":"Chinnery","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.hrthm.2019.05.007_bib380","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/CCM.0b013e31826a44f6","article-title":"Oxygen therapy in critical illness: precise control of arterial oxygenation and permissive hypoxemia","volume":"41","author":"Martin","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib381","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2010.05624.x","article-title":"MELAS and L-arginine therapy: pathophysiology of stroke-like episodes","volume":"1201","author":"Koga","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.hrthm.2019.05.007_bib382","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1399-3046.2011.01635.x","article-title":"Mitochondrial electron transport chain deficiency, cardiomyopathy, and long-term cardiac transplant outcome","volume":"16","author":"Golden","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.hrthm.2019.05.007_bib383","first-page":"325","article-title":"Kearns-Sayre syndrome: a case series of 35 adults and children","volume":"7","author":"Khambatta","year":"2014","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib384","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2014.12.038","article-title":"Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy","volume":"181","author":"Kabunga","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib385","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-0031-1299790","article-title":"The genetics of mitochondrial disease","volume":"31","author":"Davis","year":"2011","journal-title":"Semin Neurol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib386","first-page":"26","article-title":"Focal lipid cardiomyopathy in an infant with paroxysmal atrial tachycardia","volume":"95","author":"Bove","year":"1973","journal-title":"Arch Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib387","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.CIR.53.4.708","article-title":"Infantile cardiomyopathy with histiocytoid change in cardiac muscle cells. Report of six patients","volume":"53","author":"Ferrans","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib388","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s100249900007","article-title":"Histiocytoid cardiomyopathy: three new cases and a review of the literature","volume":"1","author":"Shehata","year":"1998","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib389","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2350\/10-05-0826-OA.1","article-title":"Identification of candidate genes for histiocytoid cardiomyopathy (HC) using whole genome expression analysis: analyzing material from the HC registry","volume":"14","author":"Shehata","year":"2011","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib390","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/0046-8177(93)90219-7","article-title":"Infantile histiocytoid cardiomyopathy\u2014myocardial or conduction system hamartoma: what is the cell type involved?","volume":"24","author":"Gelb","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib391","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00431240","article-title":"Congenital \"histiocytoid\" cardiomyopathy: evidence suggesting a developmental disorder of the Purkinje cell system of the heart","volume":"396","author":"Zimmermann","year":"1982","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib392","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-8703(94)90601-7","article-title":"Infantile histiocytoid cardiomyopathy: three cases and literature review","volume":"128","author":"Malhotra","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib393","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1542\/peds.48.2.312","article-title":"Infantile xanthomatous cardiomyopathy","volume":"48","author":"MacMahon","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/j.hrthm.2019.05.007_bib394","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1203\/00006450-200009000-00008","article-title":"A missense mutation in the mitochondrial cytochrome b gene in a revisited case with histiocytoid cardiomyopathy","volume":"48","author":"Andreu","year":"2000","journal-title":"Pediatr Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib395","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0008-6363(99)00315-6","article-title":"Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in\u00a0vivo","volume":"45","author":"Vallance","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib396","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000433-199503000-00017","article-title":"Sudden death in an infant due to histiocytoid cardiomyopathy. A light-microscopic, ultrastructural, and immunohistochemical study","volume":"16","author":"Ruszkiewicz","year":"1995","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib397","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1520\/JFS13547J","article-title":"Histiocytoid cardiomyopathy: case report and literature review","volume":"38","author":"Prahlow","year":"1993","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.hrthm.2019.05.007_bib398","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archpedi.1995.02170160118020","article-title":"Pathological case of the month. Histiocytoid (oncocytic) cardiomyopathy","volume":"149","author":"Heifetz","year":"1995","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib399","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/jcp.40.3.329","article-title":"Foamy myocardial transformation of infancy: an inherited disease","volume":"40","author":"Suarez","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib400","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0046-8177(88)80296-X","article-title":"Oncocytic cardiomyopathy syndrome","volume":"19","author":"Franciosi","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib401","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s004670000401","article-title":"Cardiac malformations associated with the congenital nephrotic syndrome","volume":"14","author":"Grech","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib402","doi-asserted-by":"crossref","first-page":"9C","DOI":"10.1016\/0002-9149(89)90677-2","article-title":"Pathologic anatomy of the dilated cardiomyopathies","volume":"64","author":"Ferrans","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib403","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0002-9149(83)90103-0","article-title":"Histiocytoid cardiomyopathy: a cause of sudden death in apparently healthy infants","volume":"52","author":"Saffitz","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib404","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0002-9149(72)90603-0","article-title":"Idiopathic infantile cardiomyopathy with involvement of the conduction system","volume":"30","author":"Kauffman","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib405","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0065-3101(24)00091-4","article-title":"Radiofrequency catheter ablation of cardiac arrhythmias in pediatric patients","volume":"41","author":"Van Hare","year":"1994","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.hrthm.2019.05.007_bib406","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/ajmg.a.37138","article-title":"Exome sequencing of patients with histiocytoid cardiomyopathy reveals a de novo NDUFB11 mutation that plays a role in the pathogenesis of histiocytoid cardiomyopathy","volume":"167A","author":"Shehata","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.hrthm.2019.05.007_bib407","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib408","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib409","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/01.CIR.0000034511.06350.DF","article-title":"Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation","volume":"106","author":"Rocken","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib410","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jjcc.2016.07.012","article-title":"High recurrence of atrial fibrillation in patients with high tissue atrial natriuretic peptide and amyloid levels after concomitant maze and mitral valve surgery","volume":"69","author":"Park","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib411","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","author":"Grogan","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hrthm.2019.05.007_bib412","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib413","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib414","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJMe1805499","article-title":"Oligonucleotide drugs for transthyretin amyloidosis","volume":"379","author":"Buxbaum","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib415","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJMc1814074","article-title":"Tafamidis for transthyretin amyloid cardiomyopathy","volume":"380","author":"Maurer","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib416","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib417","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9343(00)00471-X","article-title":"Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis","volume":"109","author":"Mueller","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib418","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0735-1097(97)00267-2","article-title":"Electrophysiologic abnormalities in AL (primary) amyloidosis with cardiac involvement","volume":"30","author":"Reisinger","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib419","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/clc.4960200811","article-title":"Atrioventricular sequential pacing in cardiac amyloidosis: an acute Doppler echocardiographic and catheterization hemodynamic study","volume":"20","author":"Mathew","year":"1997","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib420","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0002-9149(97)82785-3","article-title":"Symptomatic conduction system disease in cardiac amyloidosis","volume":"80","author":"Mathew","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib421","first-page":"145","article-title":"Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis","volume":"182","author":"Rezk","year":"2018","journal-title":"Br\u00a0J\u00a0Haematol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib422","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib423","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.0502287102","article-title":"In\u00a0vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2019.05.007_bib424","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1073\/pnas.1300761110","article-title":"AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin","volume":"110","author":"Penchala","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2019.05.007_bib425","first-page":"39","article-title":"Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction","volume":"8","author":"Ton","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib426","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00695078","article-title":"The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden","volume":"402","author":"Eriksson","year":"1984","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib427","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1540-8159.1984.tb05599.x","article-title":"Pacemaker treatment in familial amyloidosis with polyneuropathy","volume":"7","author":"Eriksson","year":"1984","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib428","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0167-5273(83)90217-6","article-title":"The sick sinus syndrome in familial amyloidosis with polyneuropathy","volume":"4","author":"Olofsson","year":"1983","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib429","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib430","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-76-4-599","article-title":"Systemic amyloidosis, functional coronary insufficiency, and autonomic impairment","volume":"76","author":"Capone","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib431","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9343(65)90052-5","article-title":"Peripheral and autonomic nerve involvement in primary amyloidosis associated with uncontrollable diarrhoea and steatorrhoea","volume":"39","author":"French","year":"1965","journal-title":"Am J Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib432","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4065\/83.11.1226","article-title":"Patterns of neuropathy and autonomic failure in patients with amyloidosis","volume":"83","author":"Wang","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib433","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0002-9149(85)90995-6","article-title":"Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents","volume":"55","author":"Gertz","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib434","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.104.2.618","article-title":"Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis","volume":"104","author":"Pollak","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2019.05.007_bib435","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/thx.37.9.711","article-title":"Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine","volume":"37","author":"Griffiths","year":"1982","journal-title":"Thorax"},{"key":"10.1016\/j.hrthm.2019.05.007_bib436","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/jce.13046","article-title":"Catheter ablation for atrial arrhythmias in patients with cardiac amyloidosis","volume":"27","author":"Tan","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib437","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.hrthm.2019.05.007_bib438","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijcard.2016.07.254","article-title":"Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis","volume":"222","author":"Hamon","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib439","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib440","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehp592","article-title":"Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death","volume":"31","author":"Lin","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib441","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206600","article-title":"Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis","volume":"2014","author":"Patel","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.hrthm.2019.05.007_bib442","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib443","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib444","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/01.wnl.0000276951.39112.2b","article-title":"Primary systemic amyloidosis with ischemic stroke as a presenting complication","volume":"69","author":"Zubkov","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.hrthm.2019.05.007_bib445","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","article-title":"A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis","volume":"36","author":"Sayed","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib446","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13506129.2018.1449744","article-title":"Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?","volume":"25","author":"Muchtar","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.hrthm.2019.05.007_bib447","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/01.CIR.0000118467.53182.D1","article-title":"Delay in right ventricular activation contributes to Brugada syndrome","volume":"109","author":"Tukkie","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib448","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.hrthm.2010.09.004","article-title":"Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome","volume":"7","author":"Papavassiliu","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib449","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/eurheartj\/ehp252","article-title":"Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities","volume":"30","author":"Catalano","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib450","doi-asserted-by":"crossref","first-page":"e42037","DOI":"10.1371\/journal.pone.0042037","article-title":"SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility","volume":"7","author":"van Hoorn","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2019.05.007_bib451","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib452","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.jacc.2015.08.862","article-title":"Fibrosis, connexin-43, and conduction abnormalities in the Brugada syndrome","volume":"66","author":"Nademanee","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib453","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1536\/ihj.51.17","article-title":"Right ventricular histological substrate and conduction delay in patients with Brugada syndrome","volume":"51","author":"Ohkubo","year":"2010","journal-title":"Int Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib454","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCEP.107.737882","article-title":"Absence of pathognomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome","volume":"2","author":"Zumhagen","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib455","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1161\/CIRCULATIONAHA.105.520999","article-title":"Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome","volume":"112","author":"Frustaci","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib456","doi-asserted-by":"crossref","first-page":"e003631","DOI":"10.1161\/CIRCEP.115.003631","article-title":"Relationship between arrhythmogenic right ventricular cardiomyopathy and Brugada syndrome: new insights from molecular biology and clinical implications","volume":"9","author":"Corrado","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib457","doi-asserted-by":"crossref","first-page":"e001526","DOI":"10.1161\/JAHA.114.001526","article-title":"Arrhythmogenic cardiomyopathy in a patient with a rare loss-of-function KCNQ1 mutation","volume":"4","author":"Xiong","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib458","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/emboj\/19.3.332","article-title":"A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly","volume":"19","author":"Schmitt","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib459","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1077771","article-title":"KCNQ1 gain-of-function mutation in familial atrial fibrillation","volume":"299","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.hrthm.2019.05.007_bib460","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/384078a0","article-title":"K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current","volume":"384","author":"Barhanin","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.hrthm.2019.05.007_bib461","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.CIR.0000130409.72142.FE","article-title":"Mutation in the KCNQ1 gene leading to the short QT-interval syndrome","volume":"109","author":"Bellocq","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib462","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/jce.12068","article-title":"A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation","volume":"24","author":"Bartos","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib463","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.hrthm.2009.04.015","article-title":"Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation","volume":"6","author":"Das","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib464","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.hrthm.2014.01.017","article-title":"Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young","volume":"11","author":"Bagnall","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib465","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmg.2017.02.003","article-title":"Long QT syndrome and left ventricular noncompaction in 4 family members across 2 generations with KCNQ1 mutation","volume":"60","author":"Kharbanda","year":"2017","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib466","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00380-012-0235-8","article-title":"A left ventricular noncompaction in a patient with long QT syndrome caused by a KCNQ1 mutation: a case report","volume":"28","author":"Nakashima","year":"2013","journal-title":"Heart Vessels"},{"key":"10.1016\/j.hrthm.2019.05.007_bib467","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1253\/circj.CJ-08-0339","article-title":"Isolated non-compaction of the ventricular myocardium associated with long QT syndrome: a report of 2 cases","volume":"73","author":"Ogawa","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib468","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/pr.57.4.6","article-title":"International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels","volume":"57","author":"Clapham","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.hrthm.2019.05.007_bib469","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.physiol.68.040204.100431","article-title":"An introduction to TRP channels","volume":"68","author":"Ramsey","year":"2006","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib470","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.bcp.2012.06.021","article-title":"TRPM4 channels in the cardiovascular system: physiology, pathophysiology, and pharmacology","volume":"84","author":"Abriel","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib471","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0006-291X(03)01186-0","article-title":"Identification and characterization of the murine TRPM4 channel","volume":"307","author":"Murakami","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.hrthm.2019.05.007_bib472","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00424-003-1221-x","article-title":"Intracellular nucleotides and polyamines inhibit the Ca2+-activated cation channel TRPM4b","volume":"448","author":"Nilius","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.hrthm.2019.05.007_bib473","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1172\/JCI38292","article-title":"Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I","volume":"119","author":"Kruse","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrthm.2019.05.007_bib474","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/CIRCGENETICS.109.930867","article-title":"Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease","volume":"3","author":"Liu","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib475","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/humu.21599","article-title":"Mutational spectrum in the Ca(2+)\u2013activated cation channel gene TRPM4 in patients with cardiac conductance disturbances","volume":"33","author":"Stallmeyer","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hrthm.2019.05.007_bib476","doi-asserted-by":"crossref","first-page":"e54131","DOI":"10.1371\/journal.pone.0054131","article-title":"Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2019.05.007_bib477","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2016.01.052","article-title":"Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type I","volume":"207","author":"Daumy","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib478","doi-asserted-by":"crossref","first-page":"e0181842","DOI":"10.1371\/journal.pone.0181842","article-title":"Targeted next-generation sequencing detects novel gene-phenotype associations and expands the mutational spectrum in cardiomyopathies","volume":"12","author":"Forleo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2019.05.007_bib479","doi-asserted-by":"crossref","first-page":"e002103","DOI":"10.1161\/CIRCGEN.118.002103","article-title":"TRPM4 Mutation in Patients With Ventricular Noncompaction and Cardiac Conduction Disease","volume":"11","author":"Saito","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib480","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","article-title":"Phospholamban: a crucial regulator of cardiac contractility","volume":"4","author":"MacLennan","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib481","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2019.05.007_bib482","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.hrthm.2009.01.016","article-title":"Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes","volume":"6","author":"Posch","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib483","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.hrthm.2012.12.020","article-title":"Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype?","volume":"10","author":"Groeneweg","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib484","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ahj.2011.07.028","article-title":"Mutations in the human phospholamban gene in patients with heart failure","volume":"162","author":"Medeiros","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2019.05.007_bib485","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.hrthm.2017.03.034","article-title":"Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies","volume":"14","author":"Sepehrkhouy","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib486","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","article-title":"Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?","volume":"94","author":"Basso","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib487","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/CIRCGENETICS.110.959031","article-title":"Arrhythmogenic cardiomyopathy: transgenic animal models provide novel insights into disease pathobiology","volume":"4","author":"Pilichou","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib488","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.echo.2015.04.015","article-title":"Left ventricular involvement in arrhythmogenic right ventricular dysplasia\/cardiomyopathy assessed by echocardiography predicts adverse clinical outcome","volume":"28","author":"Mast","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hrthm.2019.05.007_bib489","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/jce.12222","article-title":"Mutation-positive arrhythmogenic right ventricular dysplasia\/cardiomyopathy: the triangle of dysplasia displaced","volume":"24","author":"Te Riele","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib490","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2008.09.019","article-title":"Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity","volume":"52","author":"Sen-Chowdhry","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib491","doi-asserted-by":"crossref","first-page":"e94820","DOI":"10.1371\/journal.pone.0094820","article-title":"High resolution systematic digital histological quantification of cardiac fibrosis and adipose tissue in phospholamban p.Arg14del mutation associated cardiomyopathy","volume":"9","author":"Gho","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2019.05.007_bib492","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/his.12963","article-title":"Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation","volume":"69","author":"Te Rijdt","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.hrthm.2019.05.007_bib493","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.amjcard.2013.06.017","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers","volume":"112","author":"Groeneweg","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib494","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1249\/MSS.0b013e31820607a3","article-title":"Disproportionate exercise load and remodeling of the athlete's right ventricle","volume":"43","author":"La Gerche","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.hrthm.2019.05.007_bib495","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00246-006-0054-8","article-title":"Primary noncompaction of the ventricular myocardium from the morphogenetic standpoint","volume":"28","author":"Bartram","year":"2007","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib496","series-title":"Diagnostic Molecular Pathology","first-page":"213","article-title":"Molecular testing in inherited cardiomyopathies","author":"McLaughlin","year":"2017"},{"key":"10.1016\/j.hrthm.2019.05.007_bib497","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2005.03.045","article-title":"Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging","volume":"46","author":"Petersen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib498","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrcardio.2016.207","article-title":"Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors","volume":"14","author":"Finsterer","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib499","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(14)61282-4","article-title":"Left ventricular non-compaction cardiomyopathy","volume":"386","author":"Towbin","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib500","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/CIRCRESAHA.117.310987","article-title":"Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism","volume":"121","author":"Towbin","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2019.05.007_bib501","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.hfc.2010.06.005","article-title":"Left ventricular noncompaction: a new form of heart failure","volume":"6","author":"Towbin","year":"2010","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.hrthm.2019.05.007_bib502","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCIMAGING.111.971713","article-title":"Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis","volume":"5","author":"Kawel","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2019.05.007_bib503","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2016.08.054","article-title":"Left ventricular noncompaction: anatomical phenotype or distinct cardiomyopathy?","volume":"68","author":"Weir-McCall","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib504","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.CIR.0000100664.10777.B8","article-title":"Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy","volume":"108","author":"Pignatelli","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib505","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/CIRCGENETICS.109.903898","article-title":"The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy","volume":"3","author":"Hoedemaekers","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib506","doi-asserted-by":"crossref","first-page":"e001857","DOI":"10.1161\/CIRCGENETICS.117.001857","article-title":"Navigating genetic and phenotypic uncertainty in left ventricular noncompaction","volume":"10","author":"Rhee","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib507","doi-asserted-by":"crossref","first-page":"e001763","DOI":"10.1161\/CIRCGENETICS.117.001763","article-title":"Novel genetic triggers and genotype-phenotype correlations in patients with left ventricular noncompaction","volume":"10","author":"Miszalski-Jamka","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib508","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCGENETICS.115.001026","article-title":"Loss of function mutations in NNT are associated with left ventricular noncompaction","volume":"8","author":"Bainbridge","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hrthm.2019.05.007_bib509","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1540-8167.2011.02015.x","article-title":"Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy","volume":"22","author":"Caliskan","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib510","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.113.002511","article-title":"Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center","volume":"127","author":"Brescia","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib511","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2016.08.053","article-title":"Long-term prognostic value of cardiac magnetic resonance in left ventricle noncompaction: a prospective multicenter study","volume":"68","author":"Andreini","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib512","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/07853890.2011.554427","article-title":"Rhythm disorders in isolated left ventricular noncompaction","volume":"44","author":"Steffel","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/j.hrthm.2019.05.007_bib513","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cardfail.2011.05.002","article-title":"Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview","volume":"17","author":"Bhatia","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.hrthm.2019.05.007_bib514","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.hrthm.2016.11.014","article-title":"Ventricular arrhythmias associated with left ventricular noncompaction: electrophysiologic characteristics, mapping, and ablation","volume":"14","author":"Muser","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2019.05.007_bib515","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.amjcard.2017.07.103","article-title":"Complications associated with implantable cardioverter defibrillators in adults with congenital heart disease or left ventricular noncompaction cardiomyopathy (From the NCDR((R)) Implantable Cardioverter-Defibrillator Registry)","volume":"120","author":"Gleva","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib516","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.amjcard.2011.05.039","article-title":"Frequency of stroke and embolism in left ventricular hypertrabeculation\/noncompaction","volume":"108","author":"Stollberger","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2019.05.007_bib517","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2019.05.007_bib518","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/CIRCULATIONAHA.114.008554","article-title":"Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations","volume":"130","author":"Gati","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib519","doi-asserted-by":"crossref","first-page":"e006174","DOI":"10.1161\/CIRCIMAGING.117.006174","article-title":"Prevalence and prognostic significance of left ventricular noncompaction in patients referred for cardiac magnetic resonance imaging","volume":"10","author":"Ivanov","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2019.05.007_bib520","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/RTI.0b013e31828e9b3d","article-title":"Defining left ventricular noncompaction using cardiac computed tomography","volume":"29","author":"Sidhu","year":"2014","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.hrthm.2019.05.007_bib521","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1148\/radiol.2017161995","article-title":"Hypertrabeculated left ventricular myocardium in relationship to myocardial function and fibrosis: the Multi-Ethnic Study of Atherosclerosis","volume":"284","author":"Kawel-Boehm","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.hrthm.2019.05.007_bib522","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.CIR.82.2.507","article-title":"Isolated noncompaction of left ventricular myocardium. A study of eight cases","volume":"82","author":"Chin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2019.05.007_bib523","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/heart.86.6.666","article-title":"Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy","volume":"86","author":"Jenni","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.hrthm.2019.05.007_bib524","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.acvd.2010.01.002","article-title":"Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography","volume":"103","author":"Thuny","year":"2010","journal-title":"Arch Cardiovasc Dis"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119304382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527119304382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T17:21:52Z","timestamp":1721236912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527119304382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":524,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1547527119304382"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.05.007","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}